Novel CCR1 antagonists with improved metabolic stability
- 3 May 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (9) , 2175-2179
- https://doi.org/10.1016/j.bmcl.2004.02.022
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory DiseasesPublished by Elsevier ,2003
- CCR1 Chemokine Receptor AntagonistCurrent Pharmaceutical Design, 2003
- Development and evaluation of pharmacological agents targeting chemokine receptorsMethods, 2003
- Chemokine receptors: multifaceted therapeutic targetsNature Reviews Immunology, 2002
- Chemokines and diseaseNature Immunology, 2001
- Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3The Journal of Experimental Medicine, 1998
- Chemokines — Chemotactic Cytokines That Mediate InflammationNew England Journal of Medicine, 1998
- Chemokine-Dependent Upregulation of CD11b on Specific Leukocyte Subpopulations in Human Whole Blood: Effect of Anticoagulant on Rantes and MIP-1β StimulationCytokine, 1996
- Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptorCell, 1993